Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezogabine Long-term Extension in Epilepsy
NCT00310375Phase 3Completed
- Sponsor
- GSK
- Start
- May 2006
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of retigabine in epilepsy, sponsored by GSK. Started May 2006; status: completed.
02
Drugs
retigabine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00310375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310375.